simvastatin has been researched along with Edema-Proteinuria-Hypertension Gestosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beard, S; Binder, NK; Brownfoot, FC; de Alwis, N; Hannan, NJ; Kaitu'u-Lino, TJ; Mangwiro, YT; Tong, S | 1 |
| Brownfoot, FC; Cannon, P; Hannan, NJ; Hastie, R; Kaitu'u-Lino, TJ; Tong, S | 1 |
| Dong, X; Shi, D | 1 |
| Ahmad, S; Ahmed, A; Al-Ani, B; Cudmore, MJ; Fujisawa, T; Hewett, PW; Hollenberg, MD; Jayaraman, PS; Ohba, M; Ramma, W; Saifeddine, M; Sissaoui, S; Williams, H | 1 |
4 other study(ies) available for simvastatin and Edema-Proteinuria-Hypertension Gestosis
| Article | Year |
|---|---|
Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction.
Topics: Cell Survival; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Female; Human Umbilical Vein Endothelial Cells; Humans; Pravastatin; Pre-Eclampsia; Pregnancy; Rosuvastatin Calcium; Simvastatin; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor Receptor-1 | 2020 |
Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
Topics: Endoglin; Female; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; Rosuvastatin Calcium; Simvastatin; Trophoblasts; Up-Regulation; Vascular Endothelial Growth Factor Receptor-1 | 2016 |
Simvastatin Alleviates Pathology in a Rat Model of Preeclampsia Involving ERK/MAPK Pathway.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-10; Malondialdehyde; MAP Kinase Signaling System; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Pre-Eclampsia; Pregnancy; Rats; Simvastatin; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Endothelial Growth Factor A | 2017 |
Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells.
Topics: Carbon Monoxide; Cells, Cultured; Down-Regulation; Endothelial Cells; ErbB Receptors; Factor Xa; Female; Gene Expression; Heme Oxygenase-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; MAP Kinase Signaling System; Pre-Eclampsia; Pregnancy; Protein Kinase C; Proto-Oncogene Proteins pp60(c-src); Receptor, PAR-2; Simvastatin; Solubility; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-1 | 2010 |